Table 5 Univariate models of cost and medical personnel utilization per patient in the total cohort (n = 218)

Survived during observation period (n = 183)

2.11

(1.71, 2.61)

<0.0001

Hospitalized during ART (n = 20)

1.50

(1.13, 2.01)

0.0052

ART changed due to side effects (n = 27)

1.40

(1.09, 1.79)

0.0083

Weight above lowest quartile at baseline (n = 155)

1.25

(1.03, 1.52)

0.0244

Fewer than 5 symptoms at ART initiation (n = 147)

1.22

(1.03, 1.46)

0.0238

Physician time

Relative difference

95% CI

p-value

ART changed due to side effects or failure (n = 27)

1.62

(1.34, 1.97)

<0.0001

Survived during observation period (n = 183)

1.59

(2.18, 3.78)

<0.0001

Treated for TB (n = 33)

1.58

(1.32, 1.88)

<0.0001

Female gender (n = 122)

1.22

(1.07, 1.39)

0.0040

No Income (n = 125)

1.20

(1.05, 1.37)

0.0089

Nurse time

Relative difference

95% CI

p-value

Treated for TB (n = 33)

1.56

(1.27, 1.90)

<0.0001

Survived during observation period (n = 183)

2.13

(1.68, 2.70)

<0.0001